v3.26.1
Acquisitions - Schedule of Assets Acquired and Liabilities Assumed (Details) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Jul. 01, 2025
Apr. 01, 2025
Mar. 31, 2026
Dec. 31, 2025
Mar. 31, 2025
Mar. 31, 2026
Mar. 31, 2026
Dec. 31, 2025
Assets acquired                
Goodwill     $ 360,924,307 $ 357,211,919 [1]   $ 360,924,307 $ 360,924,307 $ 357,211,919 [1]
BioConnect                
Total Consideration:                
Cash paid $ 12,996,275         12,996,275    
Less: cash acquired (113,545)         (113,545)    
Total cash paid, net 12,882,730         12,882,730    
Assets acquired                
Accounts receivable 1,836,809   1,836,809     1,836,809 1,836,809  
Inventory 1,176,471   1,176,471     1,176,471 1,176,471  
Prepaid expenses and other current assets 111,143   111,143     111,143 111,143  
Property, plant, and equipment 63,866   63,866     63,866 63,866  
Goodwill 3,399,491   3,829,234     3,829,234 3,829,234  
Deferred tax asset 0   673,198     673,198 673,198  
Total assets acquired, excluding cash 15,852,486   15,852,486     15,852,486 15,852,486  
Liabilities assumed:                
Accounts payable 603,234   603,234     603,234 603,234  
Accrued expenses and other current liabilities 369,074   369,074     369,074 369,074  
Other liabilities 1,997,448   1,997,448     1,997,448 1,997,448  
Total liabilities assumed 2,969,756   2,969,756     2,969,756 2,969,756  
Measurement Period Adjustments                
Goodwill       $ 400,000   429,743    
Deferred tax asset           673,198    
Total assets acquired, excluding cash           0    
Net assets acquired, excluding cash           0    
Net assets acquired, excluding cash 12,882,730   12,882,730     12,882,730 12,882,730  
BioConnect | Trade names and trademarks                
Assets acquired                
Intangible asset 882,353   882,353     882,353 882,353  
BioConnect | Developed technology                
Assets acquired                
Intangible asset 6,617,647   5,514,706     5,514,706 5,514,706  
Measurement Period Adjustments                
Intangible assets           (1,102,941)    
BioConnect | Customer relationships                
Assets acquired                
Intangible asset $ 1,764,706   1,764,706     1,764,706 1,764,706  
VOXX                
Total Consideration:                
Cash paid   $ 148,256,998            
Less: cash acquired   (9,077,136)            
Total cash paid, net   139,179,862            
Fair value of previously held investment in VOXX   48,478,560     $ 48,500,000      
Total transaction consideration, net   187,658,422            
Assets acquired                
Accounts receivable   56,719,726 56,719,726     56,719,726 56,719,726  
Inventory   96,718,000 96,718,000     96,718,000 96,718,000  
Prepaid expenses and other current assets   20,294,973 20,431,540     20,431,540 20,431,540  
Income tax recoverable   5,243,038 4,280,703     4,280,703 4,280,703  
Property, plant, and equipment   44,977,000 44,977,000     44,977,000 44,977,000  
Equity investment   19,000,000 19,000,000     19,000,000 19,000,000  
Goodwill   0 16,478,978     16,478,978 16,478,978  
Deferred tax asset   32,537,099 32,673,698     32,673,698 32,673,698  
Operating lease, right of use assets   5,404,163 5,404,163     5,404,163 5,404,163  
Other assets   3,445,075 3,445,075     3,445,075 3,445,075  
Total assets acquired, excluding cash   284,339,074 300,128,883     300,128,883 300,128,883  
Liabilities assumed:                
Accounts payable   31,347,556 31,096,255     31,096,255 31,096,255  
Accrued expenses and other current liabilities   51,772,746 67,436,043     67,436,043 67,436,043  
Income taxes payable   684,033 1,061,846     1,061,846 1,061,846  
Debt   3,909,290 3,909,290     3,909,290 3,909,290  
Other tax liabilities   791,593 791,593     791,593 791,593  
Operating lease liabilities   3,435,604 3,435,604     3,435,604 3,435,604  
Other liabilities   1,260,830 1,260,830     1,260,830 1,260,830  
Total liabilities assumed   93,201,652 108,991,461     108,991,461 108,991,461  
Measurement Period Adjustments                
Prepaid expenses and other current assets             136,567  
Income tax recoverable             (962,335)  
Goodwill     16,500,000       16,478,978 $ 16,500,000
Deferred tax asset             136,599  
Total assets acquired, excluding cash             15,789,809  
Accounts payable             (251,301)  
Accrued expenses and other current liabilities             15,663,297  
Income taxes payable             377,813  
Total liabilities assumed             15,789,809  
Net assets acquired, excluding cash             0  
Redeemable and non-redeemable non-controlling interests in consolidated subsidiaries   3,479,000 3,479,000     3,479,000 3,479,000  
Net assets acquired, excluding cash   $ 187,658,422 $ 187,658,422     $ 187,658,422 $ 187,658,422  
[1] The Condensed Consolidated Balance Sheet at December 31, 2025 has been derived from the audited Consolidated Financial Statements at that date, but does not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements.